Clinical Trial Update: Immunogenicity, Efficacy and Safety of QazCovid-in® COVID-19 Vaccine [Phase 3]

View source ↗

Summary

Phase 3 trial update reporting immunogenicity, efficacy and safety data for the QazCovid-in COVID-19 vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sars

Drugs mentioned

• QazCovid-in

Snippet

Sponsor: Research Institute for Biological Safety Problems | Conditions: Covid19, SARS-CoV Infection | Phase 3 | Status: COMPLETED